| LILLY ENDOWMENT INC |
10%+ Owner |
$102,620,068,774 |
-$4,361,928,759 |
-4.1% |
07 Jan 2026 |
| David A. Ricks |
President, Chair, and CEO, Director |
$727,645,755 |
+$1,052,263 |
+0.14% |
01 Feb 2026 |
| Daniel Skovronsky |
EVP, CS&PO & Pres. LRL |
$242,176,799 |
-$3,681,660 |
-1.5% |
01 Feb 2026 |
| Stephen F. Fry |
SVP, HR & Diversity |
$101,263,226 |
|
|
09 Feb 2022 |
| J. Erik Fyrwald |
Director |
$78,212,072 |
+$1,005,242 |
+1.3% |
20 Jan 2026 |
| Anne E. White |
EVP & Pres, Lilly Neuroscience |
$69,993,126 |
|
|
10 Feb 2025 |
| Patrik Jonsson |
EVP & President, LLY Int'l |
$61,971,723 |
|
|
01 Feb 2026 |
| Ralph Alvarez |
Director |
$58,585,003 |
+$500,473 |
+0.86% |
20 Jan 2026 |
| Anat Hakim |
EVP, GC & Secretary |
$56,084,745 |
|
|
01 Feb 2026 |
| Edgardo Hernandez |
EVP & Pres., Mfg. Operations |
$44,198,639 |
|
|
01 Feb 2026 |
| JACKSON P. TAI |
Director |
$40,310,425 |
|
|
17 Apr 2023 |
| Jacob Van Naarden |
EVP,Pres LLY Oncology&HdCorpBD |
$36,465,058 |
+$647,360 |
+1.8% |
01 Feb 2026 |
| Anat Ashkenazi |
Evp & Cfo |
$34,963,818 |
|
|
12 Feb 2024 |
| Ilya Yuffa |
EVP&Pres, LLY USA&Global Capab |
$32,136,046 |
-$1,720,313 |
-5.1% |
01 Feb 2026 |
| MICHAEL L. ESKEW |
Director |
$28,606,416 |
|
|
15 Nov 2021 |
| Michael B. Mason |
EVP & Pres., Lilly Diabetes |
$27,598,461 |
|
|
10 Feb 2023 |
| Diogo Rau |
Evp & Cido |
$25,867,180 |
|
|
01 Feb 2026 |
| Katherine Baicker |
Director |
$24,012,635 |
|
|
17 Nov 2025 |
| Johna Norton |
EVP, Global Quality |
$23,684,106 |
|
|
03 Jun 2024 |
| William G. Kaelin Jr |
Director |
$22,310,672 |
|
|
17 Nov 2025 |
| Leigh Ann Pusey |
EVP, Corp. Affairs & Comm. |
$21,109,203 |
|
|
10 Feb 2023 |
| JUAN R. LUCIANO |
Director |
$17,448,538 |
|
|
20 Jan 2026 |
| Gordon J. Brooks |
Interim CFO, Group VP |
$15,299,554 |
|
|
15 Jul 2024 |
| Eric Dozier |
EVP, Chief People Officer |
$12,253,395 |
|
|
01 Feb 2026 |
| Marschall S. Runge |
Director |
$10,529,420 |
|
|
20 Nov 2023 |
| Lucas Montarce |
Evp & Cfo |
$10,158,694 |
+$494,627 |
+5.1% |
15 Aug 2025 |
| Jamere Jackson |
Director |
$9,844,584 |
+$127,913 |
+1.3% |
17 Nov 2025 |
| Kenneth L. Custer |
EVP & President, Card Met Hlth |
$8,726,907 |
|
|
27 Aug 2025 |
| Alonzo Weems |
Evp, Erm & Ceco |
$6,584,469 |
|
|
12 Feb 2024 |
| Karen Walker |
Director |
$4,544,144 |
|
|
18 Nov 2024 |
| Donald A. Zakrowski |
SVP, Finance, & CAO |
$4,375,878 |
-$3,280,080 |
-43% |
13 Nov 2025 |
| KIMBERLY H. JOHNSON |
Director |
$3,335,575 |
|
|
17 Nov 2025 |
| Melissa Seymour |
EVP, Global Quality |
$3,130,672 |
|
|
01 Aug 2025 |
| Gabrielle Sulzberger |
Director |
$3,083,713 |
+$75,018 |
+2.5% |
20 Jan 2026 |
| Adrienne S. Brown |
EVP, President LLY Imm |
$2,842,175 |
|
|
07 Nov 2025 |
| Mary Lynne Hedley |
Director |
$2,501,014 |
|
|
15 Dec 2025 |
| Carolyn R. Bertozzi |
Director |
$2,045,740 |
|
|
08 Dec 2025 |
| Jon R. Moeller |
Director |
$310,873 |
|
|
17 Nov 2025 |
| Carole Ho |
EVP & Pres, Lilly Neuroscience |
|
|
|
31 Dec 2025 |